Baculovirus Expression Vector System
Licensing Opportunities
Protein Sciences Corporation has several technologies that are available for licensing or partnering:
- expresSF+® Cell Line (product/indication specific)
- Oncology Product Candidates:
- Carcinoembryonic Antigen (CEA)
- C-5304 (anti-angiogenesis therapeutic protein)
- Erythropoietin (EPO)
- Veterinary Influenza Vaccines
For more information, please contact Joseph Rininger, Director of Business Development at 1-203-599-6064 x115 or jrininger@proteinsciences.com.
